Ming-Hsi Huang is currently working on the development of micro-/nano- encapsulation technology for a single-dose multivalent vaccine against emerging infectious diseases and investigations of sustained delivery against cancers and immune dysfunctions. His major research interest at National Health Research Institutes, Taiwan has been focused on the development of novel delivery vehicles for generating vaccine-induced long-term immunity as well as immunoregulatory agents for manipulating effective/harmful immune responses. Ming-Hsi Huang is currently working on the development of micro-/nano- encapsulation technology for a single-dose multivalent vaccine against emerging infectious diseases and investigations of sustained delivery against cancers and immune dysfunctions. His major research interest at National Health Research Institutes, Taiwan has been focused on the development of novel delivery vehicles for generating vaccine-induced long-term immunity as well as immunoregulatory agents for manipulating effective/harmful immune responses.

Vaccines & Vaccination, veterinary sciences, Animal Sciences